淋巴细胞/单核细胞比值与高胆固醇血症患者血脂水平的 相关性研究

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
刘志龙,付贤宁,毛鹏博
文章摘要
目的:探讨淋巴细胞/单核细胞比值(LMR)与高胆固醇血症患者血脂水平的相关性。方法:回顾性分析本院2023年1月至2023年6月接诊的高胆固醇血症患者,将符合诊断标准的40例高胆固醇血症患者作为观察组,选取40例同期体检健康人群作为对照组。检测外周血淋巴细胞数量、单核细胞数量并计算其比值。检测两组生化血脂水平并进行比较,包括总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1(ApoA1)、载脂蛋白B(ApoB),分析LMR与血脂水平的相关性并绘制ROC曲线评估其对高胆固醇血症的诊断效能。结果:观察组TC、LDL-C、ApoB水平均显著高于对照组(P<0.05);而LMR、HDL-C、ApoA1水平则显著低于对照组(P<0.05)。LMR与TC、LDL-C、ApoB水平负相关(P<0.05);与HDL-C、ApoA1水平呈正相关(P<0.05)。ROC曲线结果表明LMR预测高胆固醇血症的曲线下面积(AUC)为0.770,当截断值(Cut-off)为2.795时,灵敏度为77.5%,特异性为70%。结论:高胆固醇血症患者LMR与血脂水平具有较强的相关性;LMR在预测高胆固醇血症中具有良好的诊断效能。
文章关键词
高胆固醇血症;淋巴细胞/单核细胞比值;甘油三酯;胆固醇;相关性
参考文献
[1] Sharifi M,Futema M,Nair D,Humphries SE.Polygenic Hypercholesterolemia and Cardiovascular Disease Risk.Curr Cardiol Rep.2019;21(6):43. [2] Pirillo A,Norata GD.The burden of hypercholesterolemia and ischemic heart disease in an ageing world.Pharmacol Res.2023;19):106814. [3] Luo J,Yang H,Song BL.Mechanisms and regulation of cholesterol homeostasis.Nat Rev Mol Cell Biol.2020;21(4):225-245. [4] Ma X,Feng Y.Hypercholesterolemia Tunes Hematopoietic Stem/Progenitor Cells for Inflammation and Atherosclerosis.Int J Mol Sci. 2016;17(7):1162. [5] Andersen CJ.Lipid Metabolism in Inflammation and Immune Function.Nutrients.2022;14(7):1414. [6] Zhang J,Chen L,Zhou R,Sun H,Liao Y,Liao W.Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor:A Meta-Analysis.Gastroenterol Res Pract.2016;2016:9801063. [6] Ravindranathan D,Master VA,Bilen MA.Inflammatory Markers in Cancer Immunotherapy.Biology(Basel).2021;10(4):325. [7] Tudurachi BS,Anghel L,Tudurachi A,Sascău RA,Stătescu C.Assessment of Inflammatory Hematological Ratios(NLR,PLR,MLR,LMR and Monocyte/HDL-Cholesterol Ratio)in Acute Myocardial Infarction and Particularities in Young Patients.Int J Mol Sci. 2023;24(18):14378. [8] Kurtul A,Duran M.The correlation between lymphocyte/monocyte ratio and coronary collateral circulation in stable coronary artery disease patients.Biomark Med.2017;11(1):43-52. [9] Steinberg D.Hypercholesterolemia and inflammation in atherogenesis:two sides of the same coin.Mol Nutr Food Res.2005;49(11):995-998. [10] Wadström BN,Pedersen KM,Wulff AB,Nordestgaard BG.Inflammation compared to low-density lipoprotein cholesterol:two different causes of atherosclerotic cardiovascular disease.Curr Opin Lipidol.2023;34(3):96-104. [11] Michos ED,McEvoy JW,Blumenthal RS.Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.N Engl J Med.2019;381(16):1557-1567. [12] Zhu Y,Xian X,Wang Z,et al.Research Progress on the Relationship between Atherosclerosis and Inflammation.Biomolecules.2018;8(3):80. [13] Wei Y,Feng J,Ma J,Chen D,Chen J.Neutrophil/lymphocyte,platelet/lymphocyte and monocyte/lymphocyte ratios in patients with affective disorders.J Affect Disord.2022;309:221-228. [14] Zhu X,Zhou J,Zhu Y,et al.Neutrophil/lymphocyte,platelet/lymphocyte and monocyte/lymphocyte ratios in schizophrenia.Australas Psychiatry.2022;30(1):95-99. [15] Pedro-Botet J,Climent E,Benaiges D.Atherosclerosis and inflammation.New therapeutic approaches.Arteriosclerosis e inflamación. Nuevos enfoques terapéuticos.Med Clin(Barc).2020;155(6):256-262. [16] Hansson GK,Hermansson A.The immune system in atherosclerosis.Nat Immunol.2011;12(3):204-212. [17] Libby P,Bornfeldt KE,Tall AR.Atherosclerosis:Successes,Surprises,and Future Challenges.Circ Res.2016;118(4):531-534. [18] Hua Y,Sun JY,Lou YX,Sun W,Kong XQ.Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population.Int J Cardiol.2023;379:118-126. [19] Zhu X,Li R,Zhu Y,et al.Neutrophil/lymphocyte,platelet/lymphocyte,monocyte/lymphocyte ratios and systemic immune-inflammation index in patients with depression.Bratisl Lek Listy.2023;124(6):471-474.
Full Text:
DOI